Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy

To clarify the optimal cumulative cisplatin dose (CCD) in locoregionally‐advanced nasopharyngel carcinoma (NPC) patients receiving induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT). Using the NPC‐specific database from the established big‐data intelligence platform at Sun Yat‐Sen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer science 2018-03, Vol.109 (3), p.751-763
Hauptverfasser:	Lv, Jia‐Wei, Qi, Zhen‐Yu, Zhou, Guan‐Qun, He, Xiao‐Jun, Chen, Yu‐Pei, Mao, Yan‐Ping, Chen, Lei, Tang, Ling‐Long, Li, Wen‐Fei, Lin, Ai‐Hua, Ma, Jun, Sun, Ying
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - pharmacology Cancer therapies Carcinoma - drug therapy Carcinoma - radiotherapy Carcinoma - virology Chemoradiotherapy Chemotherapy Cisplatin Cisplatin - administration & dosage Cisplatin - pharmacology Clinical medicine Clinical trials cumulative cisplatin dose Databases, Factual Deoxyribonucleic acid Disease-Free Survival DNA Dose-Response Relationship, Drug Epstein-Barr virus Epstein-Barr Virus Infections - drug therapy Epstein-Barr Virus Infections - radiotherapy Epstein-Barr Virus Infections - virology Female Herpesvirus 4, Human - drug effects Herpesvirus 4, Human - genetics Humans induction chemotherapy Induction Chemotherapy - methods Intelligence intensity‐modulated radiation therapy Male Medical research Middle Aged Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms - drug therapy Nasopharyngeal Neoplasms - radiotherapy Nasopharyngeal Neoplasms - virology Original Patients Radiation therapy real world data Studies Survival Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!